Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCoats Group Plc Regulatory News (COA)

Share Price Information for Coats Group Plc (COA)

Share Price is delayed by 15 minutes
Get Live Data
78.75    -0.15 (-0.19%)
Bid:
78.60
Ask:
78.75
Spread: 0.15 (0.191%)
Market Cap: £1.51b
COA Live PriceLast checked at - London Stock Exchange

Intraday Coats Group Plc Share Chart

Trading Statement

23 Nov 2022 07:00

RNS Number : 2772H
Coats Group PLC
23 November 2022
 

 23 November 2022

Coats Group plc

 

Trading update

Trading in line with full year expectations

 

Coats Group plc ('Coats', the 'Company' or the 'Group'), the world's leading industrial thread and global footwear component manufacturer, today announces a trading update for the period 1 July 2022 to 31 October 2022 ('the period').

 

· Strong organic revenue growth of 6% year-on-year, as the Group's performance normalised, as anticipated, after the very strong result in the first half

· Year-to-date revenue growth was 14%, a run-rate above the expected long term trend

· Pricing and productivity actions continue to offset inflationary pressures

· Trading in line with full year expectations

 

1 July to 31 October 2022 revenue vs same period in 2021

Year to date revenue growth

Organic

CER

Reported

Organic

Group

6%

18%

9%

14%

A&F

3%

20%

11%

14%

Performance Materials

15%

15%

6%

16%

 

All following references are on an organic CER basis.

 

The growth rate of 6% year-on-year reflects the strong prior year comparator and moderated compared to H1 due to an industry-wide softening in demand, mainly in Apparel, towards the end of the period.

Apparel and Footwear revenue increased 3% year-on-year in the period and 14% year-to-date. Apparel experienced some destocking by customers, as a result of the macroeconomic environment. Footwear continued to see positive end market sentiment across the US, Europe and Asia. The acquisitions of Texon and Rhenoflex are performing in line with our expectations.

 

Revenue in Performance Materials increased 15% with all segments continuing to perform well.

 

Our pricing actions and self-help efficiency programmes continue to offset the significant inflationary pressures in the supply chain. In addition, our strategic projects remain on-track, and are delivering significant operational and financial benefits.

 

Balance sheet

 

The Group maintains a strong and liquid balance sheet with proforma leverage currently around 1.5 times, following the recent Footwear acquisitions. This remains within the Group's targeted leverage range of between 1 - 2 times.

 

Outlook

 

The Group is proactively responding to macroeconomic uncertainty with a well-defined and tested playbook that focuses on cost and cash actions. Consequently the Group anticipates that its performance for the full year 2022 will be in line with expectations, despite greater foreign exchange headwinds than were expected at the half year (a 3-4% full year adjusted operating profit headwind has increased to c.5% based on latest rates). The Group continues to expect to make good progress during 2023 underpinned by the full year contribution of acquisitions, associated synergies, and strategic projects.

 

 

The Group will release its full year 2022 results on 2 March 2023.

 

Appendix:

 

1 January to 31 October 2022 revenue vs same period in 2021

Organic

CER

Reported

Group

14%

19%

12%

A&F

14%

20%

14%

Performance Materials

16%

16%

8%

 

 

 

 

Enquiry details

 

 

 

Investors

Chris Dyett

Coats Group plc

+44 (0)79 7497 4690

Media

Richard Mountain / Nick Hasell

FTI Consulting

+44 (0)20 3727 1374

 

 

 

About Coats Group plc

Coats is a world leader in thread manufacturing and structural components for apparel and footwear, as well as an innovative pioneer in performance materials. These critical solutions are used to create a wide range of products, including ones that provide safety and protection for people, data and the environment. Headquartered in the UK, Coats is a FTSE250 company and a FTSE4Good Index constituent. Revenues in 2021 were $1.8bn.

Trusted by the world's leading companies to deliver crucial, innovative, and sustainable solutions, Coats provides value-adding products including apparel, accessory and footwear threads, structural footwear components, fabrics, yarns and software applications. Customer partners include companies from the apparel, footwear, automotive, telecoms, personal protection, and outdoor goods industries.

With a proud heritage dating back more than 250 years and spirit of evolution to constantly stay ahead of changing market needs, Coats has operations across some 50 countries with a workforce of over 17,000, serving its customers worldwide. 

Coats connects talent, textiles, and technology, to make a better and more sustainable world. Worldwide, there are three dedicated Coats Innovation Hubs, where experts collaborate with partners to create the materials and products of tomorrow. It participates in the UN Global Compact and is committed to Science Based sustainability targets for 2030 and beyond, with a goal of achieving net-zero by 2050. Coats is also committed to achieving its goals in Diversity, Equity & Inclusion, workplace health & safety, employee & community wellbeing, and supplier social performance.

To find out more about Coats visit www.coats.com.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTBKBBPCBDDKDB
Date   Source Headline
4th Mar 20217:00 amRNS2020 Full Year Results
3rd Mar 20217:00 amRNSRemuneration and Audit Committee Changes
26th Feb 202110:52 amRNSTotal Voting Rights
2nd Feb 202111:30 amRNSHolding(s) in Company
28th Jan 202111:07 amRNSHolding(s) in Company
31st Dec 20201:31 pmRNSTotal Voting Rights
23rd Dec 20207:00 amRNSDirector/PDMR Shareholding
1st Dec 20204:05 pmRNSDirector/PDMR Shareholding
26th Nov 202011:11 amRNSDirector/PDMR Shareholding
24th Nov 20207:00 amRNSNew Chairman appointment
23rd Nov 20202:29 pmRNSHolding(s) in Company
5th Nov 202012:36 pmRNSHolding(s) in Company
3rd Nov 20207:00 amRNSTrading Statement
14th Oct 20207:00 amRNSConfirmation of CFO Designate start date
6th Oct 202011:09 amRNSBlock listing Interim Review
22nd Sep 20207:00 amRNSDirector Declaration
13th Aug 20207:00 amRNSHalf-year Report
29th Jul 20207:00 amRNSAppointment of Chief Financial Officer Designate
29th Jun 20209:25 amRNSHolding(s) in Company
11th Jun 20203:17 pmRNSResult of AGM
27th May 20204:47 pmRNSDirector/PDMR Shareholding
20th May 20207:00 amRNSTrading Statement
18th May 20202:28 pmRNSNotice of AGM
18th May 202010:03 amRNSDirectorate Change
13th May 20203:06 pmRNSNotice of AGM
28th Apr 20205:24 pmRNSHolding(s) in Company
28th Apr 20201:21 pmRNSNotice of AGM
27th Apr 20202:01 pmRNSDisclosure of rights attached to securities
23rd Apr 20201:48 pmRNSHolding(s) in Company
3rd Apr 20202:13 pmRNSBlock listing Interim Review
2nd Apr 20204:30 pmRNSHolding(s) in Company
1st Apr 20207:00 amRNSDirectorate Change
27th Mar 20207:00 amRNSTrading Statement
24th Mar 20204:19 pmRNSHolding(s) in Company
23rd Mar 20209:48 amRNSHolding(s) in Company
20th Mar 20204:45 pmRNSSecond Price Monitoring Extn
20th Mar 20204:36 pmRNSPrice Monitoring Extension
12th Mar 20202:52 pmRNSDirector/PDMR Shareholding
12th Mar 202010:46 amRNSDirector/PDMR Shareholding
11th Mar 202010:14 amRNSHolding(s) in Company
10th Mar 20201:31 pmRNSAnnual Financial Report
9th Mar 20208:13 amRNSDirector/PDMR Shareholding
6th Mar 20202:18 pmRNSDirector/PDMR Shareholding
6th Mar 20202:17 pmRNSDirector/PDMR Shareholding
6th Mar 20208:23 amRNSHolding(s) in Company
5th Mar 20207:00 amRNSFinal Results
2nd Mar 202011:03 amRNSAdditional Listing
28th Feb 20203:48 pmRNSTotal Voting Rights
14th Feb 20201:29 pmRNSHolding(s) in Company
11th Feb 20207:00 amRNSAcquisition

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.